BrightBid Group AB (publ) Cash Flow Conversion Efficiency

Latest as of March 2026: -0.071x

BrightBid Group AB (publ) cash flow conversion efficiency. Based on the latest financial reports, BrightBid Group AB (publ) (PERP-B) has a cash flow conversion efficiency ratio of -0.071x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.03 Million ≈ $-218.68K USD) by net assets (Skr28.54 Million ≈ $3.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of BrightBid Group AB (publ) (2012–2025)

Cash flow conversion efficiency of BrightBid Group AB (publ) from 2012 to 2025. This chart illustrates how BrightBid Group AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View BrightBid Group AB (publ) stock quote for real-time trading data and today's change.

BrightBid Group AB (publ) Cash Flow Conversion Ratio Explained

BrightBid Group AB (publ) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

BrightBid Group AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BrightBid Group AB (publ) ranked by their cash flow conversion efficiency. Also see PERP-B company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Yangaroo Inc
V:YOO
0.540x
Mercia Technologies PLC
LSE:MERC
0.032x
Tivic Health Systems Inc
NASDAQ:TIVC
-0.453x
ModuLink Inc.
NASDAQ:MDLK
-1.967x
Lazydays Holdings Inc
NASDAQ:GORV
0.889x
Triangle Energy (Global) Ltd
AU:TEG
3.581x
Elevai Labs, Inc. Common Stock
NASDAQ:ELAB
-0.119x
BioSenic S.A.
BR:BIOS
0.059x

Annual Cash Flow Conversion Efficiency for BrightBid Group AB (publ) (2012–2025)

The table below shows the annual cash flow conversion efficiency of BrightBid Group AB (publ) from 2012 to 2025. Review free cash flow generation of BrightBid Group AB (publ) to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr30.77 Million
≈ $3.31 Million
Skr-5.46 Million
≈ $-587.91K
-0.178x +72.55%
2024-12-31 Skr10.87 Million
≈ $1.17 Million
Skr-7.03 Million
≈ $-756.25K
-0.647x +68.19%
2023-12-31 Skr8.07 Million
≈ $868.57K
Skr-16.41 Million
≈ $-1.77 Million
-2.033x -48.69%
2022-12-31 Skr14.03 Million
≈ $1.51 Million
Skr-19.19 Million
≈ $-2.06 Million
-1.368x -85.77%
2021-12-31 Skr20.83 Million
≈ $2.24 Million
Skr-15.34 Million
≈ $-1.65 Million
-0.736x -7.92%
2020-12-31 Skr14.97 Million
≈ $1.61 Million
Skr-10.21 Million
≈ $-1.10 Million
-0.682x +16.19%
2019-12-31 Skr17.03 Million
≈ $1.83 Million
Skr-13.86 Million
≈ $-1.49 Million
-0.814x -1.25%
2018-12-31 Skr13.72 Million
≈ $1.48 Million
Skr-11.03 Million
≈ $-1.19 Million
-0.804x +3.28%
2017-12-31 Skr11.24 Million
≈ $1.21 Million
Skr-9.34 Million
≈ $-1.01 Million
-0.831x +88.04%
2016-12-31 Skr1.32 Million
≈ $141.82K
Skr-9.16 Million
≈ $-985.37K
-6.948x -555.55%
2015-12-31 Skr5.53 Million
≈ $595.30K
Skr-5.86 Million
≈ $-630.95K
-1.060x -485.35%
2014-12-31 Skr6.12 Million
≈ $659.05K
Skr-1.11 Million
≈ $-119.34K
-0.181x +12.07%
2013-12-31 Skr4.21 Million
≈ $453.06K
Skr-867.00K
≈ $-93.30K
-0.206x -263.26%
2012-12-31 Skr4.06 Million
≈ $436.60K
Skr-230.00K
≈ $-24.75K
-0.057x --

About BrightBid Group AB (publ)

ST:PERP-B USA Medical Devices
Market Cap
$1.57 Million
Skr14.63 Million SEK
Market Cap Rank
#30281 Global
#6178 in USA
Share Price
Skr1.71
Change (1 day)
-5.26%
52-Week Range
Skr1.71 - Skr5.56
All Time High
Skr5.56
About

Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of dr… Read more